Zimmer Biomet shares fall 7.7% after CFO departure
Updated
Updated · MarketWatch · Apr 28
Zimmer Biomet shares fall 7.7% after CFO departure
14 articles · Updated · MarketWatch · Apr 28
Chief Financial Officer Suketu Upadhyay is leaving Zimmer Biomet to join Incyte as finance chief on May 4.
Paul Stellato, chief accounting officer, has been appointed interim CFO while the company searches for a permanent successor.
Despite the leadership change, Zimmer Biomet reported first-quarter profit of $238.1 million and sales of $2.09 billion, both exceeding analysts’ expectations.
Can Zimmer Biomet's push into AI and robotics overcome market jitters caused by its sudden CFO departure?
Zimmer Biomet is overhauling its salesforce. Is this a genius move or a risky gamble during a leadership transition?
How will a simultaneous CFO search and salesforce overhaul impact Zimmer Biomet's ability to compete in the robotics market?
As CFO turnover plagues healthcare, what does this exit reveal about the pressures on med-tech's top financial executives?
Why did a CFO exit a company with record profits, causing its stock to plunge despite a rosy forecast?